A detailed history of Cibc World Markets Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Cibc World Markets Corp holds 236,102 shares of ABT stock, worth $29.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
236,102
Previous 223,978 5.41%
Holding current value
$29.5 Million
Previous $23.3 Million 15.66%
% of portfolio
0.2%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $1.21 Million - $1.43 Million
12,124 Added 5.41%
236,102 $26.9 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $5.03 Million - $5.61 Million
49,929 Added 28.69%
223,978 $23.3 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $5.4 Million - $5.97 Million
-49,317 Reduced 22.08%
174,049 $19.8 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $11.6 Million - $14.2 Million
-128,715 Reduced 36.56%
223,366 $24.6 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $9.74 Million - $11.7 Million
101,991 Added 40.78%
352,081 $34.1 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $12.6 Million - $14 Million
124,756 Added 99.54%
250,090 $27.3 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $7.71 Million - $9.08 Million
-79,650 Reduced 38.86%
125,334 $12.7 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $17 Million - $19.9 Million
178,412 Added 671.43%
204,984 $22.5 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $9.26 Million - $10.7 Million
-95,661 Reduced 78.26%
26,572 $2.57 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $24.7 Million - $29.8 Million
-241,543 Reduced 66.4%
122,233 $13.3 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $3.45 Million - $4.21 Million
30,288 Added 9.08%
363,776 $43.1 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $7.69 Million - $9.41 Million
-66,533 Reduced 16.63%
333,488 $46.9 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $32.3 Million - $35.7 Million
276,653 Added 224.25%
400,021 $47.3 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $4.82 Million - $5.67 Million
-45,524 Reduced 26.95%
123,368 $14.3 Million
Q1 2021

May 07, 2021

SELL
$108.84 - $128.23 $17.2 Million - $20.2 Million
-157,683 Reduced 48.28%
168,892 $20.2 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $2.29 Million - $2.5 Million
21,835 Added 7.17%
326,575 $35.8 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $12 Million - $14.6 Million
131,047 Added 75.45%
304,740 $33.2 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $3.59 Million - $4.59 Million
-46,858 Reduced 21.25%
173,693 $15.9 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $725,822 - $1.06 Million
11,554 Added 5.53%
220,551 $17.4 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $33.5 Million - $37.3 Million
-426,638 Reduced 67.12%
208,997 $18.2 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $18.4 Million - $19.9 Million
224,423 Added 54.58%
635,635 $53.2 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $1.87 Million - $2.18 Million
-25,611 Reduced 5.86%
411,212 $34.6 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $8.79 Million - $10.6 Million
-132,805 Reduced 23.31%
436,823 $34.9 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $3.78 Million - $4.29 Million
57,728 Added 11.28%
569,628 $41.2 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $6.64 Million - $8.02 Million
109,263 Added 27.14%
511,900 $37.6 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $3.84 Million - $4.24 Million
66,735 Added 19.87%
402,637 $24.6 Million
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $10.2 Million - $11.5 Million
-181,070 Reduced 35.03%
335,902 $20.1 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $13.5 Million - $14.5 Million
252,069 Added 95.16%
516,972 $29.5 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $12.7 Million - $14.2 Million
264,903
264,903 $14.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $219B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.